- £426.53m
- £588.63m
- £1.77bn
- 63
- 56
- 36
- 49
R2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 857 | 1,235 | 1,745 | 1,983 | 1,769 |
Cost of Revenue | |||||
Gross Profit | 469 | 666 | 945 | 1,041 | 895 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 798 | 1,144 | 1,621 | 1,973 | 1,851 |
Operating Profit | 58.7 | 90.9 | 124 | 9.4 | -82.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 59.9 | 92.2 | 125 | 7.8 | -90.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 47.5 | 72.9 | 93.4 | -4 | -75.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 43.6 | 63.7 | 90.7 | -4 | -75.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 43.6 | 63.7 | 90.7 | -4 | -75.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.042 | 0.053 | 0.076 | 0.007 | -0.018 |